Retraction notice to "Polydatin protects against calcium oxalate crystal-induced renal injury through the cytoplasmic/mitochondrial reactive oxygen species-NLRP3 inflammasome pathway" [Biomedicine & Pharmacotherapy 167 (2023) 115621] - 21/05/26
Doi : 10.1016/j.biopha.2026.119406
Jiannan Liu a, Jianlin Huang a, Bo Gong a, Songtao Cheng a, Yadong Liu b, c, Yaodong Chen d, Qiang Feng a, Jun Li a, Mingxing Qiu a, Gui Yu a, ⁎, Yong Liao a, ⁎
a Department of Urology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China
b Department of Urology, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China
c Department of Urology, Ningbo First Hospital, Zhejiang 315000, China
d Department of Ultrasonic Imaging, The First Affiliated Hospital of Shanxi Medical University, Shanxi 030001, China
⁎ Corresponding authors.
Le texte complet de cet article est disponible en PDF.
© 2026
The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 199
Article 119406- juin 2026 Retour au numéro
Article précédent
- Retraction notice to “Taraxerol, a pentacyclic triterpenoid, from Abroma augusta leaf attenuates diabetic nephropathy in type 2 diabetic rats” [Biomedicine & Pharmacotherapy 94 (2017) 726-741]
- Ritu Khanra, Niloy Bhattacharjee, Tarun K. Dua, Ashis Nandy, Achintya Saha, Jatin Kalita, Prasenjit Manna, Saikat Dewanjee
- Retraction notice to "A review on metal complexes and its anti-cancer activities: Recent updates from in vivo studies" [Biomedicine & Pharmacotherapy 171 (2024) 116211]
- Suman Adhikari, Priyatosh Nath, Alakesh Das, Abhijit Datta, Nabajyoti Baildya, Asim K. Duttaroy, Surajit Pathak
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?